WHRY pilot project recipients have received major competitive funding support to advance their work toward clinical applications.
- May 06, 2020
Caroline Johnson, Ph.D., Assistant Professor of Epidemiology in the Department of Environmental Health Sciences at Yale School of Public Health and a member of Yale Cancer Center’s Cancer Microbiology Research Program, has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society (ACS).
- March 18, 2020
Researchers have found that colon cancer tumor cells produce energy for growth differently in women and men, and that this difference is associated with a more aggressive form of tumor growth with a higher incidence in women.
- December 20, 2019Source: Nature
Change is a constant in the burgeoning feld of metabolomics. That includes data analysis tools and repositories
- June 17, 2019
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
- April 24, 2019
Chronic alcohol abuse is considered to be an important risk factor for disease worldwide. In addition, alcohol and its metabolite, acetaldehyde, are recognized as carcinogens that contribute to four percent of cancer deaths. Although scientific studies began to show this association over 100 years ago, the role of alcohol in chronic diseases such as cancer is still not well understood by the public and medical professionals. The 4th International Conference on Alcohol and Cancer was organized by Vasilis Vasiliou, PhD, the Susan Dwight Bliss Professor of Epidemiology, sponsored by the Department of Environmental Health Sciences of the Yale School of Public Health, and supported by an R13 grant from the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The conference, held in Newport, R.I., brought together 75 international scholars with special interest in alcohol and/or cancer.
- December 10, 2018
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.
- September 28, 2018
In the past decade, the list of cancers clearly associated with obesity or excessive weight has been growing: breast, kidney, uterine, pancreatic, colorectal, and esophageal cancers all are linked to obesity.
- February 09, 2018Source: BMC Blog Network
Through the combination of genomics and metabolomics research, scientists are getting closer to understanding the impact of environmental exposure and lifestyle on disease onset. This recently designated "exposotype" (which takes into account genomic and metabolic data) is a new tool researchers can potentially use to refine and revolutionize current thinking about precision medicine and risk assessment.
- December 08, 2017
Yale School of Public Health symposium on lifetime exposures and human health: the exposome; summary and future reflectionsSource: Human Genomics
The exposome is defined as “the totality of environmental exposures encountered from birth to death” and was developed to address the need for comprehensive environmental exposure assessment to better understand disease etiology.